Ending the HIV Epidemic: A Plan for the United States

Affiliations

¹ National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland.
² Centers for Disease Control and Prevention, US Department of Health and Human Services, Atlanta, Georgia.
³ Health Resources & Services Administration, US Department of Health and Human Services, Rockville, Maryland.
⁴ Indian Health Service, US Department of Health and Human Services, Rockville, Maryland.
⁵ Office of the Assistant Secretary for Health, US Department of Health and Human Services, Washington, DC.

Anthony S Fauci et al. JAMA. 2019.

. 2019 Mar 5;321(9):844-845.

doi: 10.1001/jama.2019.1343.

¹ National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland.
² Centers for Disease Control and Prevention, US Department of Health and Human Services, Atlanta, Georgia.
³ Health Resources & Services Administration, US Department of Health and Human Services, Rockville, Maryland.
⁴ Indian Health Service, US Department of Health and Human Services, Rockville, Maryland.
⁵ Office of the Assistant Secretary for Health, US Department of Health and Human Services, Washington, DC.

No abstract available

Comment in

False information on PrEP in direct-to-consumer advertising.
Nunn AS, Goedel WC, Gomillia CE, Coats CS, Patel RR, Murphy MJ, Chu CT, Chan PA, Mena LA. Nunn AS, et al. Lancet HIV. 2020 Jul;7(7):e455-e456. doi: 10.1016/S2352-3018(20)30034-5. Epub 2020 Feb 4. Lancet HIV. 2020. PMID: 32032537 No abstract available.
PrEP for HIV Prevention: Evidence, Global Scale-up, and Emerging Options.
Celum C, Baeten J. Celum C, et al. Cell Host Microbe. 2020 Apr 8;27(4):502-506. doi: 10.1016/j.chom.2020.03.020. Cell Host Microbe. 2020. PMID: 32272075